Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ: MEDP )

342.92 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Want $1 Million in Retirement? Invest $200,000 in These 3 Stocks and Wait a Decade
A basket balanced evenly across these three businesses could jump-start your journey to becoming a millionaire. 
Via The Motley Fool
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2022 Results
From Medpace Holdings, Inc.
Via Business Wire
Earnings Scheduled For February 13, 2023
Companies Reporting Before The Bell • EuroDry (NASDAQ:EDRY) is expected to report quarterly earnings at $2.68 per share on revenue of $21.20 million. 
Via Benzinga
Medpace Hldgs's Earnings: A Preview
Via Benzinga
Why Medpace Stock Soared Today
The clinical trial specialist is winning new business at an impressive clip. 
Via The Motley Fool
Better Healthcare Buy for 2023: Medpace Holdings or Doximity?
The healthcare stocks expect similar revenue growth in 2023. 
Via The Motley Fool
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 13, 2023
From Medpace Holdings, Inc.
Via Business Wire
Dow Jones Giant UnitedHealth Among 5 Resilient Stocks In Sickly Market Rally
UnitedHealth is among medical stocks holding key support. 
Via Investor's Business Daily
Veracyte Stock Showing Market Leadership; Earns 93 RS Rating
Veracyte shows rising price performance, earning an upgrade to its IBD Relative Strength Rating. 
Via Investor's Business Daily
These 4 Superb Growth Stocks Are Beating the Nasdaq Bear Market: Is It Too Late to Buy?
There's good reason to expect these businesses to continue their histories of outperformance, regardless of market conditions. 
Via The Motley Fool
Contract Research Organization Medpace Lifts FY22 Guidance, Highlights FY23 Outlook
Via Benzinga
Coke's Fizz, Weber's Proposed Deal, and Stock Market Superstitions
There's a lot for investors to think about. 
Via The Motley Fool
Why Medpace Holdings Jumped 41.5% This Week
The clinical contract research organization is seeing an increase in new business. 
Via The Motley Fool
Stock Market Rally Resilient As Apple Bucks Megacap Meltdown: Weekly Review
The Dow and S&P 500 moved above a key level while the Nasdaq rose. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 27, 2022
Upgrades 
Via Benzinga
Why Taysha Gene Therapies Shares Jumped Over 97%; Here Are 70 Biggest Movers From Yesterday
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. 
Via Benzinga
Nasdaq Surges Over 200 Points; General Electric Posts Downbeat Earnings
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Stocks Pop As "Fear Gauge" Cools Off
Stocks have shrugged off premarket losses and are confidently higher ahead of Big Tech earnings. 
Via Talk Markets
Medpace Earnings Are 'Almost Unbelievable'; MEDP Stock Flies
Medpace earnings soared in Q3 as weakness in contract awards turned to strength, sending MEDP stock surging. 
Via Investor's Business Daily
S&P 500 Rises Over 1%; General Motors Earnings Top Views
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.8% on Tuesday. 
Via Benzinga
Peering Into Medpace Hldgs's Recent Short Interest
Medpace Hldgs's (NASDAQ:MEDP) short percent of float has risen 11.68% since its last report. The company recently reported that it has 2.20 million shares sold short, which is 10.52% of all regular... 
Via Benzinga
Why Crown Holdings Shares Are Trading Lower By Around 22%? Here Are 46 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
Aaron's, Celestica, Medpace Holdings And Some Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
$1000 Invested In Medpace Hldgs 5 Years Ago Would Be Worth This Much Today
Medpace Hldgs (NASDAQ:MEDP) has outperformed the market over the past 5 years by 35.08% on an annualized basis producing an average annual return of 43.37%. Currently, Medpace Hldgs has a market... 
Via Benzinga
US Stocks Open Higher; Dow Rises Over 100 Points
U.S. stocks traded higher this morning, with the Dow Jones surging more than 100 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Taysha Gene Therapies (NASDAQ:TSHA) stock increased by 36.4% to $2.06 during Tuesday's pre-market session. The market value of their outstanding shares is at $84.6 million. 
Via Benzinga
Medpace Holdings, Inc. Reports Third Quarter 2022 Results
From Medpace Holdings, Inc.
Via Business Wire
Preview: Medpace Hldgs's Earnings
Medpace Hldgs (NASDAQ:MEDP) is set to give its latest quarterly earnings report on Monday, 2022-10-24. Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs... 
Via Benzinga
Earnings Scheduled For October 24, 2022
Companies Reporting Before The Bell • Imperial Ptrl (NASDAQ:IMPP) is likely to report earnings for its third quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.